Hims & Hers Health, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD 109.90 M

Hims & Hers Health, Inc. EBIT is USD 109.90 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -1,426.14% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Hims & Hers Health, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -8.29 M, a -86.85% change year over year.
  • Hims & Hers Health, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -63.04 M, a -32.38% change year over year.
  • Hims & Hers Health, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -93.23 M, a 61.96% change year over year.
  • Hims & Hers Health, Inc. EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -57.56 M, a -1.58% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)